All Stories

  1. In Silico Design of New B-Raf Kinase Type-II Inhibitors Through Combined Molecular Modeling Studies
  2. Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors
  3. In silico Prediction of Inhibitory Constant of Thrombin Inhibitors Using Machine Learning